6 stories from 5 sources
Supporting Articles
Anthropic is planning an initial public offering in November, later than the October debut some investors expected. The timing may allow the company to include third-quarter financial results that are expected to show strong performance.
8:08 PMPYMNTS
Nscale has filed to pursue a US listing that could value the British data centre operator at $35 billion. The company has also secured a major contract to supply computing capacity to Anthropic.
4:26 PMFinancial Times
Manus is in talks to raise $500 million at a $4 billion valuation after ending its planned merger with Meta earlier this year. The company is returning to independent operations as it seeks new capital.
12:35 PMTechCrunchSummary
Anthropic is planning an initial public offering in November, later than the October debut some investors expected. The timing may allow the company to include third-quarter financial results that are expected to show strong performance.
Anthropic appears to be using the delay to enter public markets with stronger financial evidence,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Anthropic's IPO could set a new valuation and disclosure benchmark for the private AI market.
Summary
Nscale has filed to pursue a US listing that could value the British data centre operator at $35 billion. The company has also secured a major contract to supply computing capacity to Anthropic.
The proposed valuation shows how demand for AI infrastructure is moving private data centre operators
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Nscale's filing could set a new public-market benchmark for AI data centre infrastructure.
Summary
Manus is in talks to raise $500 million at a $4 billion valuation after ending its planned merger with Meta earlier this year. The company is returning to independent operations as it seeks new capital.
The proposed valuation would test investor confidence in Manus without Meta's backing or resources. The
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Manus's financing will show whether investors still value the company as a standalone AI startup after its failed Meta tie-up.
A curated list of other prominent stories from this day.
UP.Labs, now operating as Vantora, has raised $100 million to build startups for industrial corporations, with a focus on physical AI.
7:25 PMTechCrunch
Skalar has emerged from stealth with more than $125 million in committed deployments across six businesses. The fintech also announced a seed round led by Monashees and a capital partnership with General Catalyst's Customer Value Fund to finance growth-stage technology startups.
2:32 PMFinextraPTX Capital is targeting AI-enabled healthcare businesses that support clinical and operational systems rather than investing directly in drug assets. The US venture firm views these tools as a core opportunity in healthcare technology.
1:49 AMBloomberg MarketsSummary
UP.Labs, now operating as Vantora, has raised $100 million to build startups for industrial corporations, with a focus on physical AI.
The funding gives Vantora capital to turn industrial problems into standalone companies rather than selling
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Vantora is betting that industrial AI will scale through purpose-built startups created alongside the companies that need to use them.
Summary
Skalar has emerged from stealth with more than $125 million in committed deployments across six businesses. The fintech also announced a seed round led by Monashees and a capital partnership with General Catalyst's Customer Value Fund to finance growth-stage technology startups.
Skalar is positioning itself between venture capital and traditional lending by providing structured growth financing
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Skalar could expand funding options for Latin American startups after their initial venture rounds.
Summary
PTX Capital is targeting AI-enabled healthcare businesses that support clinical and operational systems rather than investing directly in drug assets. The US venture firm views these tools as a core opportunity in healthcare technology.
The shift directs venture capital toward healthcare infrastructure, software, and services instead of therapeutics. That
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
AI investors are increasingly betting on the systems around healthcare delivery, not only on breakthroughs in medicine.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!